Code | Description |
---|---|
S0145 | Injection, pegylated interferon alfa-2a, 180 mcg per ml |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatitis | D006505 | — | K75.9 | 14 | 125 | 86 | 89 | 47 | 343 |
Hepatitis a | D006506 | EFO_0007305 | B15 | 11 | 104 | 74 | 88 | 42 | 305 |
Hepatitis c | D006526 | — | B19.2 | 10 | 96 | 77 | 68 | 30 | 269 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | 7 | 59 | 55 | 52 | 24 | 189 |
Chronic hepatitis | D006521 | — | K73.9 | 8 | 39 | 30 | 39 | 16 | 122 |
Hepatitis b | D006509 | — | — | 6 | 28 | 14 | 26 | 17 | 84 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 6 | 31 | 13 | 28 | 12 | 84 |
Hiv infections | D015658 | EFO_0000764 | B20 | 7 | 18 | 9 | 5 | 3 | 38 |
Infections | D007239 | EFO_0000544 | — | 3 | 18 | 7 | 3 | — | 29 |
Carcinoma | D002277 | — | C80.0 | 1 | 8 | 6 | 1 | — | 15 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | 12 | 8 | — | 2 | 21 |
Hepatitis d | D003699 | EFO_0007304 | — | 1 | 9 | 3 | — | 2 | 14 |
Leukemia | D007938 | — | C95 | 1 | 7 | 5 | — | — | 11 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 2 | 4 | — | 5 | 10 |
Chronic hepatitis d | D019701 | — | — | 1 | 5 | 3 | — | 1 | 9 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | 4 | 5 | — | — | 8 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | 3 | 3 | — | 1 | 7 |
Fibrosis | D005355 | — | — | — | 2 | 3 | — | 3 | 7 |
Polycythemia vera | D011087 | — | D45 | 1 | 2 | 3 | — | — | 6 |
Polycythemia | D011086 | EFO_0005804 | D75.1 | 1 | 2 | 3 | — | — | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Herpesviridae infections | D006566 | EFO_0007309 | B00.4 | — | 3 | — | — | — | 3 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | — | 1 | — | — | 2 | 3 |
Sarcoma | D012509 | — | — | 2 | 1 | — | — | — | 3 |
Kaposi sarcoma | D012514 | — | C46 | 2 | 1 | — | — | — | 3 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 2 |
Multiple myeloma | D009101 | — | C90.0 | — | 2 | — | — | — | 2 |
Plasma cell neoplasms | D054219 | — | — | — | 2 | — | — | — | 2 |
Lymphoid leukemia | D007945 | — | C91 | 1 | 2 | — | — | — | 2 |
Adenocarcinoma | D000230 | — | — | — | 1 | — | — | — | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 5 | — | — | — | 1 | 6 |
Psoriasis | D011565 | EFO_0000676 | L40 | 2 | — | — | — | — | 2 |
Liver failure | D017093 | — | K72.9 | 1 | — | — | — | — | 1 |
Hepatic insufficiency | D048550 | — | — | 1 | — | — | — | — | 1 |
Alcoholic liver cirrhosis | D008104 | EFO_1000802 | K70.3 | 1 | — | — | — | — | 1 |
Plexiform neurofibroma | D018318 | EFO_0000658 | — | 1 | — | — | — | — | 1 |
Neurofibroma | D009455 | EFO_0000622 | — | 1 | — | — | — | — | 1 |
Papillomavirus infections | D030361 | — | — | 1 | — | — | — | — | 1 |
Anus neoplasms | D001005 | EFO_0003835 | C21 | 1 | — | — | — | — | 1 |
Squamous cell carcinoma | D002294 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 1 | 1 |
Chronic fatigue syndrome | D015673 | EFO_0004540 | G93.31 | — | — | — | — | 1 | 1 |
Cognition disorders | D003072 | — | — | — | — | — | — | 1 | 1 |
Substance-related disorders | D019966 | EFO_0003890 | F13 | — | — | — | — | 1 | 1 |
Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 1 | 1 |
Portal hypertension | D006975 | EFO_0000666 | K76.6 | — | — | — | — | 1 | 1 |
Ascites | D001201 | — | R18 | — | — | — | — | 1 | 1 |
Esophageal and gastric varices | D004932 | EFO_0009545 | I85 | — | — | — | — | 1 | 1 |
Drug common name | Interferon alfa-2a |
INN | — |
Description | Pegylated interferon alfa-2a, sold under the brand name Pegasys among others, is medication used to treat hepatitis C and hepatitis B. For hepatitis C it is typically used together with ribavirin and cure rates are between 24 and 92%. For hepatitis B it may be used alone. It is given by injection under the skin.
|
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | 120608 |
ChEMBL ID | CHEMBL2108508 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00008 |
UNII ID | — |